Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status...
Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Patients in refractory status epilepticus (RSE) may require treatment with continuous intravenous anesthetic drugs (cIVADs) for seizure control. The use of cIVADs, however, was recently associated with poor outcome in status epilepticus (SE), raising the question of whether cIVAD therapy should be delayed for attempts to halt seizures with repeated...
Alternative Titles
Full title
Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0d8f9d289b2c4acda67e6c8b01b3d0ba
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0d8f9d289b2c4acda67e6c8b01b3d0ba
Other Identifiers
ISSN
1364-8535
E-ISSN
1466-609X,1364-8535,1366-609X
DOI
10.1186/s13054-018-2235-2
